T
TransChromix LLC
biotechChapel Hillgrant
Chapel Hill therapeutics company developing brain-penetrant small molecules for Alzheimer's disease and other conditions using chromatin-activity-based chemoproteomics.
At a glance
- HQ: Chapel Hill
- Sector: Biotech
- Stage: Grant
- Affiliation: UNC
This is the free preview.
The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.